Case Clinical Trials Unit
Case Clinical Trials Unit
批准号:
8609928
负责人:
MICHAEL MARCEL LEDERMAN
金额:
$306.52万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-02-13 至 2020-11-30
关键词:
AIDS clinical trial groupAfricaAreaBasic ScienceClinical ResearchClinical TrialsClinical Trials NetworkClinical Trials UnitDevelopmentDiseaseEnrollmentEvaluationFacultyHIVHIV InfectionsHIV Vaccine Trials NetworkHIV vaccineHealthHepatitisInfectionInflammationInternationalJointsLeadershipLinkLogisticsMedical centerMicrobicide Trials NetworkModelingMonitorNational Institute of Allergy and Infectious DiseaseOrganPerformancePersonsPopulationPositioning AttributePreventionPrevention approachProductivityProtocols documentationRANTESResearchResearch InfrastructureResearch PriorityRoleSiteTestingTranslational ResearchTuberculosisUgandaUniversitiesWorkclinical research sitedesignhigh riskmembermicrobicidenoveloutreach programpreventprogramsresponsetransmission processtreatment trial
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Case Clinical Trials Unit (CTU) comprises four highly productive clinical research sites: Case/UHC and Metro Health Medical Center in Cleveland, the University of Cincinnati and the Joint Clinical Research Center in Kampala. Each of these four CRS sites is a top performing ACTG treatment trial site with excellent accruals, outstanding performance evaluations and major roles in the leadership of the network and it is scientific productivity. A key theme of this CTU is the close link of our clinical research portfolo with our basic and translational research programs. Thus the four CRS sites of the Case CTU bring a comprehensive research plan to the enterprise. Led by faculty who are national and international leaders in their fields, these units are poised to make substantive contributions to each of the priority areas targeted by the ACTG: Inflammation/End Organ Disease, Cure, Hepatitis and Tuberculosis. The Case/UHC CRS has also been a productive member of the MTN since the network began and proposes to develop studies in the MTN of a highly effective microbicide candidate (5P12-RANTES) that it has been developing for the past 10 years. Both Case/UHC and JCRC sites provide strong rationale for inclusion in the HVTN. Case/UHC has been working with the network on HVTN 505 and has developed a model outreach program more than doubling its enrollment to this high priority HVTN trial. The University of Cincinnati CRS is a highly efficient, well-managed CRS that has been conducting clinical and translational research for the ACTG since 1987. JCRC, the site of the first HIV vaccine trial in Africa, has ready access to large numbers of subjects in well-defined populations at high risk for HIV infection and has the advanced infrastructure to become a powerful contributor to this network. Thus the four CRS sites that comprise this CTU are positioned to provide sustained leadership and contribution to the treatment and prevention agenda of the NIAID Networks.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
-
批准号:9292706
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2016
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
-
批准号:8841193
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2014
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Targeting Cytolytic Cells to Lymphoid Sites of HIV Persistence.
-
批准号:8930055
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2014
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Effects of IL-6 blockade in treated HIV infection
-
批准号:8617799
-
项目类别:
-
资助金额:$119.07万
-
财政年份:2013
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Effects of IL-6 blockade in treated HIV infection
-
批准号:9005805
-
项目类别:
-
资助金额:$160.33万
-
财政年份:2013
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Effects of IL-6 blockade in treated HIV infection
-
批准号:8510992
-
项目类别:
-
资助金额:$73.94万
-
财政年份:2013
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
-
批准号:7391001
-
项目类别:
-
资助金额:$158.58万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Developing RANTES analogues as topical strategies to prevent HIV transmission
-
批准号:7418081
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
-
批准号:8115015
-
项目类别:
-
资助金额:$194.93万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
-
批准号:7666054
-
项目类别:
-
资助金额:$238.95万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
-
批准号:7879534
-
项目类别:
-
资助金额:$157.97万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
-
批准号:7934706
-
项目类别:
-
资助金额:$240.0万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Defining the Pathogenesis of Immune Deficiency in Chronic HIV Infection
-
批准号:8303401
-
项目类别:
-
资助金额:$191.27万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
-
批准号:7631141
-
项目类别:
-
资助金额:$155.27万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Administrative Core
-
批准号:7418083
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2008
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
2007 Case CFAR Annual Spring Conference
-
批准号:7338941
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2007
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Case Clinical Trials Unit
-
批准号:9178619
-
项目类别:
-
资助金额:$197.74万
-
财政年份:2007
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Case AIDS Clinical Trials Unit
-
批准号:7996022
-
项目类别:
-
资助金额:$314.02万
-
财政年份:2007
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Case AIDS Clinical Trials Unit
-
批准号:7570701
-
项目类别:
-
资助金额:$305.7万
-
财政年份:2007
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
Case AIDS Clinical Trials Unit
-
批准号:7355586
-
项目类别:
-
资助金额:$255.06万
-
财政年份:2007
-
负责人:MICHAEL MARCEL LEDERMAN
-
依托单位:
海外基金